Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.66
-0.14 (-0.79%)
At close: Mar 9, 2026, 4:00 PM EDT
18.01
+0.35 (1.98%)
After-hours: Mar 9, 2026, 4:12 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.4 billion as of March 9, 2026. Its market cap has increased by 243.37% in one year.
Market Cap
1.40B
Enterprise Value
1.05B
1-Year Change
243.37%
Ranking
Category
Stock Price
$17.66
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.40B, an increase of 65.46%. That is a compound annual growth rate of 11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.41B | 38.07% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 1.50B |
| Biohaven | 1.49B |
| Ardelyx | 1.48B |
| Rapport Therapeutics | 1.48B |
| Olema Pharmaceuticals | 1.43B |
| Zenas BioPharma | 1.40B |
| MBX Biosciences | 1.38B |
| AtaiBeckley | 1.34B |